Related content

Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report

By        

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3064-3066

Spandidos Publications

Access to resources Recommend Favorite

Bortezomib: A valuable new antineoplastic strategy in multiple myeloma

By Bladé Joan   Cibeira M. Teresa   Rosiñol Laura  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 440-448

Informa Healthcare

Access to resources Recommend Favorite

Intravenous gammaglobulin-induced chronic renal failure in a patient with multiple myeloma

By Sevinc Alper   Camci Celalettin   Buyukberber Suleyman   Akgul Bulent  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 357-359

Humana Press, Inc

Access to resources Recommend Favorite

Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

By Szturz Petr  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1324-1326

Informa Healthcare

Access to resources Recommend Favorite

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

By Romano A.   Chiarenza A.   Consoli U.   Conticello C.   Forte S.   Uccello G.   Vetro C.   Cavalli M.   Coppolino F.   Palumbo G. A.   Di Raimondo F.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1038-1044

Oxford University Press

Access to resources Recommend Favorite